Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
NVIDIA
NVDA
|
+$546M |
| 3 |
Boeing
BA
|
+$405M |
| 4 |
Linde
LIN
|
+$405M |
| 5 |
Exxon Mobil
XOM
|
+$316M |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.42B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$319M |
| 3 |
Microsoft
MSFT
|
+$292M |
| 4 |
Accenture
ACN
|
+$277M |
| 5 |
Lam Research
LRCX
|
+$271M |
Sector Composition
| 1 | Technology | 26.07% |
| 2 | Healthcare | 13.09% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Ramaco Resources Class A
METC
$2.01B
| $579K | ﹤0.01% |
68,010
-651
| -0.9% | -$5.54K |
|
2727
Quad
QUAD
$342M
| $579K | ﹤0.01% |
134,887
-2,337
| -2% | -$10K |
|
2728
John Marshall Bancorp
JMSB
$289M
| $578K | ﹤0.01% |
26,753
-9,624
| -26% | -$208K |
|
|
SBOW
2729
DELISTED
SilverBow Resources, Inc.
SBOW
| $576K | ﹤0.01% |
25,228
-977
| -4% | -$22.3K |
|
2730
Blue Ridge Bankshares
BRBS
$392M
| $573K | ﹤0.01% |
56,229
-5,041
| -8% | -$51.4K |
|
2731
Ocugen
OCGN
$443M
| $573K | ﹤0.01% |
672,249
-483,391
| -42% | -$412K |
|
|
SRTA
2732
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$448M
| $569K | ﹤0.01% |
168,356
-17,116
| -9% | -$57.8K |
|
2733
Digimarc
DMRC
$226M
| $569K | ﹤0.01% |
28,978
-1,675
| -5% | -$32.9K |
|
2734
Douglas Elliman
DOUG
$279M
| $569K | ﹤0.01% |
192,293
-290,655
| -60% | -$860K |
|
2735
iRadimed
IRMD
$902M
| $569K | ﹤0.01% |
14,454
-7,660
| -35% | -$302K |
|
2736
Shore Bancshares
SHBI
$577M
| $569K | ﹤0.01% |
39,842
-15,005
| -27% | -$214K |
|
|
HLTH
2737
DELISTED
Cue Health Inc. Common Stock
HLTH
| $569K | ﹤0.01% |
312,952
-32,004
| -9% | -$58.2K |
|
2738
First Bancorp
FNLC
$306M
| $564K | ﹤0.01% |
21,795
-9,484
| -30% | -$245K |
|
2739
Century Casinos
CNTY
$81.4M
| $563K | ﹤0.01% |
76,767
-687
| -0.9% | -$5.04K |
|
2740
Veru
VERU
$51.6M
| $563K | ﹤0.01% |
48,475
-5,791
| -11% | -$67.3K |
|
|
TVRD
2741
Tvardi Therapeutics, Inc. Common Stock
TVRD
$370M
| $562K | ﹤0.01% |
3,177
-368
| -10% | -$65.1K |
|
2742
Janux Therapeutics
JANX
$1.45B
| $555K | ﹤0.01% |
45,903
-14,814
| -24% | -$179K |
|
2743
Quantum-Si Incorporated
QSI
$312M
| $555K | ﹤0.01% |
315,598
-4,705
| -1% | -$8.27K |
|
2744
Rimini Street
RMNI
$430M
| $555K | ﹤0.01% |
134,666
-1,305
| -1% | -$5.38K |
|
2745
Tarsus Pharmaceuticals
TARS
$2.24B
| $552K | ﹤0.01% |
43,880
-5,185
| -11% | -$65.2K |
|
2746
Adicet Bio
ACET
$67.4M
| $545K | ﹤0.01% |
94,685
-5,326
| -5% | -$30.7K |
|
2747
The ONE Group
STKS
$80.8M
| $545K | ﹤0.01% |
67,187
-465
| -0.7% | -$3.77K |
|
2748
Alerus Financial
ALRS
$587M
| $529K | ﹤0.01% |
32,934
-14,116
| -30% | -$227K |
|
2749
BARK
BARK
$142M
| $529K | ﹤0.01% |
364,542
-42,515
| -10% | -$61.7K |
|
2750
El Pollo Loco
LOCO
$300M
| $521K | ﹤0.01% |
54,292
-9,172
| -14% | -$88K |
|